Immatics (IMTX) Interest Coverage Ratio (2019 - 2026)
Immatics (IMTX) posted Interest Coverage Ratio of 0.01 for Q4 2025, down 100.01% sequentially from 176.34 in Q3 2025, and up 99.99% YoY from 0.01 in Q4 2024.
Powered by 
Analysis
Immatics (IMTX) Interest Coverage Ratio (2019 - 2026) Analysis & Trends
Immatics has reported Interest Coverage Ratio for 7 years, with the latest figure at 0.01 in Q4 2025.
- Quarterly Interest Coverage Ratio rose 99.99% year-over-year to 0.01 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 3.28 (down 488.26% YoY) and the FY2025 annual result came in at 4.96, down 116.98% from the prior year.
- Interest Coverage Ratio retreated to 0.01 in Q4 2025 per IMTX's latest filing, from 176.34 in the prior quarter.
- Over five years, Interest Coverage Ratio peaked at 176.34 in Q3 2025 and troughed at 185.51 in Q4 2024.
- A 5-year average of 10.25 and a median of 3.8 in 2024 frame the typical range for Interest Coverage Ratio.
- The sharpest annual moves came in 2024 and 2025: Interest Coverage Ratio sank 7031.94% in 2024, then soared 14756.71% in 2025.
- Over 5 years, Interest Coverage Ratio stood at 52.49 in 2021, then sank by 94.96% to 2.65 in 2022, then sank by 198.33% to 2.6 in 2023, then tumbled by 7031.94% to 185.51 in 2024, then soared by 99.99% to 0.01 in 2025.
- According to Business Quant data, Interest Coverage Ratio over the past three periods registered 0.01, 176.34, and 2.13 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | -493.00 |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -21.24 |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 8.18 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 2.82 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 1.42 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -0.08 |
| 10 | Immatics | 1.17 Bn | 711.21 Mn | - | 184.63 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 184.63 |
| Mar 31, 2026 | 148.13 |
| Dec 31, 2025 | 75.50 |
| Sep 30, 2025 | 189.04 |
| Jun 30, 2025 | 2.33 |
| Mar 31, 2025 | 2.65 |
| Dec 31, 2024 | 0.22 |
| Sep 30, 2024 | -0.04 |
| Jun 30, 2024 | 87.10 |
| Mar 31, 2024 | 19.90 |
| Dec 31, 2023 | 9.58 |
| Sep 30, 2023 | 21.12 |
| Jun 30, 2023 | 12.51 |
| Mar 31, 2023 | 7.53 |
| Dec 31, 2022 | -0.01 |
| Sep 30, 2022 | 51.47 |
| Jun 30, 2022 | 40.93 |
| Mar 31, 2022 | -61.32 |
| Dec 31, 2021 | 49.26 |
| Sep 30, 2021 | 134.51 |